Physician profile
Eugene Mitchell Long
NPI 1477996965
$33,584.50
in general payments reported to CMS, 2019-2025
99 companies · $4,565 in 2025
The $4,565 reported for 2025 was more than what 81% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,082 · 2020: $5,080 · 2021: $3,874 · 2022: $7,048 · 2023: $4,110 · 2024: $6,825 · 2025: $4,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Honoraria: $2,600 · Education: $374 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,351.46 |
| Honoraria | $2,600.00 |
| Education | $373.90 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,770.22 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Novocure INC. | $2,718.95 | 2021-2024 | Optune Lua (Novottf-200t) |
| Daiichi Sankyo INC. | $2,333.10 | 2020-2025 | Enhertu, Injectafer, Datroway |
| Novartis Pharmaceuticals Corporation | $1,791.73 | 2019-2025 | Kisqali, Piqray |
| Astrazeneca Pharmaceuticals LP | $1,742.82 | 2019-2025 | Lynparza, Tagrisso, Calquence |
| Merck Sharp & Dohme LLC | $1,580.71 | 2019-2025 | Keytruda, Lynparza, Welireg |
| G1 Therapeutics, INC. | $1,524.04 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $1,273.99 | 2019-2025 | Opdivo, Opdualag |
| Janssen Biotech, INC. | $1,269.09 | 2019-2025 | Erleada, Tecvayli, Balversa |
| Genentech USA, INC. | $982.68 | 2019-2025 | Tecentriq, Rozlytrek, Alecensa |
| Pfizer INC. | $847.94 | 2019-2025 | |
| Genzyme Corporation | $824.22 | 2019-2025 | |
| Seagen INC. | $806.20 | 2019-2023 | Tukysa, Tivdak, Adcetris |
| Incyte Corporation | $804.73 | 2019-2025 | Monjuvi, Pemazyre, Jakafi |
| Gilead Sciences, INC. | $714.83 | 2021-2025 | Trodelvy |
Show all 99 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $630.84 | 2019-2025 | Cabometyx |
| Taiho Oncology, INC. | $619.17 | 2020-2025 | |
| Octapharma USA, INC. | $594.73 | 2020-2021 | |
| Eisai INC. | $506.02 | 2019-2025 | |
| Astellas Pharma US INC | $465.20 | 2019-2025 | Xtandi, Vyloy, Padcev |
| Regeneron Healthcare Solutions, INC. | $461.61 | 2019-2024 | Libtayo |
| Alexion Pharmaceuticals, INC. | $412.75 | 2019-2025 | Ultomiris |
| Lilly USA, LLC | $382.78 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Celgene Corporation | $379.83 | 2019-2025 | Reblozyl, Opdivo, Abecma |
| Puma Biotechnology, INC. | $341.16 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $301.95 | 2022-2025 | Fotivda |
| Array Biopharma INC | $301.25 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Jazz Pharmaceuticals INC. | $295.22 | 2020-2025 | |
| Abbvie INC. | $291.41 | 2020-2025 | |
| Ipsen Biopharmaceuticals, INC | $256.76 | 2019-2025 | Onivyde, Somatuline Depot |
| Amgen INC. | $252.72 | 2019-2023 | Blincyto, Kyprolis |
| Karyopharm Therapeutics INC. | $240.92 | 2020-2024 | Xpovio |
| Emd Serono, INC. | $234.00 | 2020-2025 | Tepmetko |
| Pharmacyclics LLC, An Abbvie Company | $228.24 | 2020-2023 | Imbruvica, Epkinly |
| Beigene USA, INC. | $220.79 | 2020-2025 | Brukinsa, Tevimbra |
| Sanofi-Aventis U.S. LLC | $220.77 | 2020-2023 | |
| Stemline Therapeutics INC. | $220.19 | 2023-2025 | Orserdu |
| Takeda Pharmaceuticals U.S.A., INC. | $213.92 | 2019-2025 | Fruzaqla, Ninlaro, Alunbrig |
| Rigel Pharmaceuticals, INC. | $185.78 | 2020-2024 | Rezlidhia, Tavalisse |
| Kite Pharma, INC. | $168.20 | 2020-2025 | Yescarta |
| Deciphera Pharmaceuticals INC. | $154.61 | 2020-2024 | Qinlock, Tgct |
| Acrotech Biopharma INC. | $154.10 | 2021-2025 | Beleodaq |
| Kyowa Kirin, INC. | $150.09 | 2019-2025 | Poteligeo |
| Bayer Healthcare Pharmaceuticals INC. | $145.70 | 2019-2025 | |
| Geron Corporation | $125.86 | 2025 | Rytelo |
| Pharmaessentia USA Corporation | $115.35 | 2022-2025 | Besremi |
| Siemens Medical Solutions USA, INC. | $113.67 | 2024 | Truebeam, Aria Radiation Therapy Management Software |
| Dova Pharmaceuticals | $96.31 | 2020-2021 | |
| Adaptive Biotechnologies Corporation | $93.40 | 2021-2023 | Clonoseq |
| Coherus Oncology, INC. | $91.09 | 2021-2025 | Udenyca |
| Adc Therapeutics America, INC. | $89.58 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.84 | 2019-2023 | Gilotrif |
| Clovis Oncology, INC. | $86.93 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $84.98 | 2019-2025 | Provenge |
| Genmab U.S., INC. | $83.79 | 2023-2025 | Epkinly, Tivdak |
| Sumitomo Pharma America, INC. | $81.32 | 2023-2025 | Orgovyx |
| Sun Pharmaceutical Industries INC. | $79.72 | 2021-2023 | Odomzo, Yonsa |
| Servier Pharmaceuticals LLC | $73.24 | 2022-2024 | |
| Morphosys, US INC. | $71.99 | 2021-2022 | |
| Agios Pharmaceuticals, INC. | $71.54 | 2020-2025 | Pyrukynd |
| Tersera Therapeutics LLC | $67.53 | 2021-2025 | Zoladex |
| Myovant Sciences INC. | $64.24 | 2022 | |
| Beone Medicines USA, INC. | $64.09 | 2025 | Brukinsa |
| Blueprint Medicines Corporation | $57.84 | 2020-2024 | Ayvakit |
| Fennec Pharmaceuticals, INC. | $54.11 | 2024-2025 | Fyarro, Pedmark |
| Spectrum Pharmaceuticals INC. | $52.42 | 2024-2025 | Rolvedon |
| Azurity Pharmaceuticals, INC. | $52.39 | 2025 | Danziten |
| Sobi, INC | $48.07 | 2022-2025 | |
| Mirati Therapeutics, INC. | $43.60 | 2023 | Krazati |
| Iovance Biotherapeutics, INC. | $42.76 | 2025 | Amtagvi |
| Lexicon Pharmaceuticals, INC. | $38.14 | 2020 | |
| Eusa Pharma (US) LLC | $31.12 | 2019-2020 | |
| Tg Therapeutics, INC. | $30.39 | 2022 | |
| Tesaro, INC. | $27.76 | 2019 | |
| Verastem, INC. | $26.28 | 2019 | |
| Becton, Dickinson and Company | $25.65 | 2019 | |
| Pharmaand Gmbh | $24.35 | 2025 | Rubraca |
| Tolmar, INC. | $24.35 | 2025 | Rubraca, Eligard |
| Tempus Ai, INC | $23.40 | 2025 | Xt Cdx |
| Amneal Pharmaceuticals LLC | $23.25 | 2024 | Avastin |
| Recordati_rare_diseases_inc. | $22.70 | 2025 | Sylvant |
| Avyxa Pharma, LLC | $22.15 | 2025 | |
| Inari Medical, INC. | $21.13 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Blue Earth Diagnostics | $20.63 | 2023 | |
| Immunocore Limited | $20.19 | 2025 | Kimmtrak |
| Cti Biopharma Corp. | $19.13 | 2023 | Vonjo |
| Springworks Therapeutics, INC. | $18.32 | 2024 | Ogsiveo |
| Medtronic USA, INC. | $18.31 | 2020 | |
| Csl Behring | $15.63 | 2019 | |
| Fortovia Therapeutics, INC. | $15.46 | 2020 | |
| Pharmacosmos Therapeutics INC. | $14.11 | 2020 | |
| Alnylam Pharmaceuticals INC. | $13.67 | 2024 | Givlaari |
| Acceleron Pharma, INC. | $12.83 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.69 | 2020 | |
| Secura Bio, INC. | $12.58 | 2020 | |
| Aurobindo Pharma USA, INC. | $11.99 | 2020 | |
| Sirtex Medical INC | $10.49 | 2019 | |
| Janssen Pharmaceuticals, INC | $9.73 | 2019 | |
| Aspira Women'S Health INC | $7.45 | 2024 | Ova1 |
Drugs and devices associated with these payments
Optune Lua (Novottf-200t) $2,600Keytruda $845Enhertu $682Lynparza $585Tukysa $325Libtayo $306Jevtana $298Scemblix $280Ultomiris $274Inqovi $267Lonsurf $267Braftovi $260Cabometyx $255Fabhalta $254Ibrance $252Imbruvica $238Trodelvy $235Opdivo $228Jaypirca $227Verzenio $227Mektovi $225Orserdu $220Kisqali $216Erleada $209Brukinsa $207Tecentriq $204Avastin $181Injectafer $173Adcetris $173Lorbrena $172Xtandi $166Zepzelca $165Opdualag $158Rozlytrek $158Alecensa $158Tagrisso $155Elrexfio $154Lenvima $144Orgovyx $137Calquence $137Polivy $126Rytelo $126Monjuvi $124Comirnaty $115Fotivda $114Onivyde $112Tasigna $110Welireg $109Gavreto $109Venclexta $109Besremi $102Pemazyre $99.63Ojjaara $99.34Qinlock $96.20Datroway $95.41Retevmo $95.34Beleodaq $92.40Epkinly $87.39Paxlovid $85.56Truebeam $84.22Vanflyta $82.05Yescarta $80.64Xpovio $76.49Rezlidhia $76.46Tavalisse $76.46Tecvayli $75.98Provenge $74.04Bosulif $73.98Padcev $72.97Piqray $72.30Lunsumio $70.42Xalkori $68.63Balversa $68.43Talzenna $66.08Cablivi $63.92Enjaymo $63.92Sarclisa $62.95Darzalex $62.85Vyloy $59.68Fruzaqla $57.13Phesgo $56.93Tivdak $56.85Promacta $54.62Jakafi $54.32Rybrevant $54.21Talvey $53.86Columvi $53.38Rolvedon $52.42Danziten $52.39Gilotrif $50.90Tevimbra $49.08Rubraca $48.70Pyrukynd $48.26Eliquis $44.68Clonoseq $44.57Krazati $43.60Akeega $43.54Amtagvi $42.76Stivarga $42.42Emrelis $41.94
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.